The eye condition, known as non-arteritic anterior ischemic optic neuropathy, can cause significant vision loss and has been reported with all GLP-1 drugs,
<iframe src="https://hindustansphere.com/embed/cluster/a3f5ff16603bc121ee6e22b047517121088c8e69" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="FDA adds rare vision-loss warning to popular obesity, diabetes drugs"></iframe>
The eye condition, known as non-arteritic anterior ischemic optic neuropathy, can cause significant vision loss and has been reported with all GLP-1 drugs,
